Drug Shortage Report for MINT-GLICLAZIDE MR
Report ID | 222750 |
Drug Identification Number | 02423286 |
Brand name | MINT-GLICLAZIDE MR |
Common or Proper name | Gliclazide |
Company Name | MINT PHARMACEUTICALS INC |
Market Status | MARKETED |
Active Ingredient(s) | GLICLAZIDE |
Strength(s) | 30MG |
Dosage form(s) | TABLET (EXTENDED-RELEASE) |
Route of administration | ORAL ORAL |
Packaging size | 100 count bottle |
ATC code | A10BB |
ATC description | BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2024-01-08 |
Estimated end date | 2024-06-30 |
Actual end date | |
Shortage status | Actual shortage |
Updated date | 2024-03-19 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 6575 DAVAND DRIVE MISSISSAUGA, ONTARIO CANADA L5T 2M3 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v2 | 2024-03-19 | French | Compare |
v1 | 2024-03-19 | English | Compare |
Showing 1 to 2 of 2